bioRxivPharmacology & ToxicologyPreprint
Lysophosphatidic Acid (LPA) Salivary Species Detection and Whole-mount LPA Receptor Localization in Mouse Salivary Gland
DELIE ROSELYN CERUTISiD, Devendra KumariD, Michael G. NicholsiD, Gabrielle Rae Roemer, Maxwell Fluent, Takanari Miyamoto, Yazen AlnoutiiD
- Citations
- 0
Abstract
This study builds on our previous findings on the role of salivary lysophosphatidic acid (LPA) species in humans to investigate their presence, together with salivary gland LPA receptor (LPAR) expression in a Porphyromonas gingivalis-infected murine (C57BL/6J) model of periodontal disease (PD). Utilizing LC-MS/MS for LPA analysis alongside confocal LPAR imaging and second harmonic (SHG) imaging for collagen visualization, we compared mouse salivary LPA levels and gland LPAR expression to previously established human and mouse data. The findings reveal that while healthy mouse saliva maintains low homeostatic LPA levels, PD triggers an [~] 10-fold increase, mirroring the elevation we observed in PD patients. Furthermore, the study confirmed the presence of LPA1, LPA3, and LPA4 within submandibular gland (SMG) tissue. Notably, LPA3 was identified as the most widely distributed subtype, while providing the first evidence of LPA4 expression in adult mouse salivary glands. The presence of multiple LPARs suggests that LPA signaling is a critical factor in salivary gland biology. The documented existence of multiple LPARs within salivary glands indicates that they must be taken into consideration in future research concerning autoimmune conditions, and in pharmacological studies involving drugs that impact salivary gland biology and secretory function.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The parotid secretory protein BPIFA2 is a salivary surfactant that affects LPS action
S. R. Nandula, I. Huxford, … S.-U. Gorr·bioRxiv·Feb 8, 2020
- Activation of macrophages by lysophosphatidic acid through the lysophosphatidic acid receptor 1 as a novel mechanism in multiple sclerosis pathogenesis.
Jennifer Fransson, Ana Isabel Gómez-Conde, … Beatriz García-Díaz·Molecular NeurobiologyPeer-reviewed·Sep 24, 2020
- Structural Mechanisms Underlying Distinct Binding and Activities of 18:0 and 18:1 Lysophosphatidic acids at LPA1 Receptor
Ayobami Diyaolu, Peter Obi, … Senthil Natesan·PLoS Computational BiologyPeer-reviewed·Apr 24, 2026
- Lysophosphatidic acid receptor 1 influences disease severity in a mouse model of multiple sclerosis
Nagi Uemura, Nagisa Matsuo, … Hisashi Shirakawa·bioRxiv·May 28, 2024
- Conditional Lpar1 gene targeting identifies cell types mediating neuropathic pain
- LPA3: Pharmacodynamic differences between lysophosphatidic acid and oleoyl-methoxy glycerophosphothionate. Biased agonism, two sites.
Karina Helivier Solís, María Teresa Romero‐Ávila, … Jesús Adolfo García-Sáinz·ReceptorsPeer-reviewed·Dec 20, 2024